Btn2a2-deficient mice showed enhanced effector CD4+ and CD8+ T cell responses, impaired CD4+ regulatory T cell induction, potentiated antitumor responses, and exacerbated experimental autoimmune encephalomyelitis (137). Here, CD4 is linked to experimental autoimmune encephalomyelitis.